𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endocrine profile in the long-term phase of converting-enzyme inhibition

✍ Scribed by Swartz, Stephen L; Williams, Gordon H; Hollenberg, Norman K; Crantz, Frank R; Moore, Thomas J; Levine, Lawrence; Sasahara, Arthur A; Dluhy, Robert G

Book ID
109842898
Publisher
Nature Publishing Group
Year
1980
Tongue
English
Weight
724 KB
Volume
28
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metabolic effects of long-term angiotens
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition
✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements